In Israel, they found a way to improve the quality of milk without the use of antibiotics

게시됨 2023년 8월 10일

Tridge 요약

Israeli biopharmaceutical company Mileutis has completed clinical trials of a new antimicrobial substitute that improves the quality of milk in dairy cows. The trials were carried out on seven Israeli dairy farms, involving over 500 cows. The results showed an increase in protein and fat content in the milk, as well as an increase in milk yield, which could impact milk prices and benefit the consumer market.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

The Israeli biopharmaceutical company Mileutis announced the completion of clinical trials of an antimicrobial substitute developed on its basis. The results showed that the use of the drug improves the quality of milk in dairy cows. It is reported by Reuters. As follows from the Mileutis statement, trials of a new non-steroidal, non-antibiotic drug for the treatment of udder inflammation in cows were carried out on seven Israeli dairy farms in conjunction with Strauss Health, part of which is owned by the French Danone. In total, more than 500 dairy cows were involved in the study. According to the results, in the milk of cows treated, the protein content increased by 7.2%, fat - by 4%. An increase in milk yield was also noted, which increased by 8.6% per cow over 305 days. “In addition to increasing milk yields and ...
출처: Milknews

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.